835 filings
Page 4 of 42
6-K
KZIA
Kazia Therapeutics Limited
20 Jan 23
Current report (foreign)
7:59am
6-K
KZIA
Kazia Therapeutics Limited
17 Jan 23
Current report (foreign)
8:24am
6-K
KZIA
Kazia Therapeutics Limited
15 Dec 22
Kazia Launches Preclinical Collaboration with Qimr Berghofer Medical Research Institute and Announces Patent Filing
7:45am
6-K
KZIA
Kazia Therapeutics Limited
12 Dec 22
Kazia Announces Receipt of Nasdaq Minimum Bid Notification
4:01pm
6-K
KZIA
Kazia Therapeutics Limited
1 Dec 22
Current report (foreign)
4:13pm
6-K
KZIA
Kazia Therapeutics Limited
16 Nov 22
Current report (foreign)
9:27am
6-K
KZIA
Kazia Therapeutics Limited
16 Nov 22
Current report (foreign)
7:24am
6-K
KZIA
Kazia Therapeutics Limited
3 Nov 22
Current report (foreign)
7:30am
6-K
KZIA
Kazia Therapeutics Limited
27 Oct 22
Current report (foreign)
7:21am
20-F
2022 FY
KZIA
Kazia Therapeutics Limited
Annual report (foreign)
17 Oct 22
7:09am
6-K
KZIA
Kazia Therapeutics Limited
14 Oct 22
Current report (foreign)
7:05am
6-K
KZIA
Kazia Therapeutics Limited
15 Sep 22
Current report (foreign)
9:12am
6-K
KZIA
Kazia Therapeutics Limited
8 Sep 22
Current report (foreign)
5:06pm
6-K
KZIA
Kazia Therapeutics Limited
1 Sep 22
Current report (foreign)
4:07pm
6-K
KZIA
Kazia Therapeutics Limited
5 Aug 22
Kazia Therapeutics Reports Promising Interim Data from Combination Study of Paxalisib with Radiotherapy In Treatment of Brain Metastases
8:18am
6-K
KZIA
Kazia Therapeutics Limited
1 Aug 22
Kazia Provides Progress Update on GBM Agile Pivotal Study
8:51am
6-K
KZIA
Kazia Therapeutics Limited
6 Jul 22
Current report (foreign)
6:04am
6-K
KZIA
Kazia Therapeutics Limited
30 Jun 22
Current report (foreign)
6:04am
6-K
KZIA
Kazia Therapeutics Limited
23 Jun 22
Current report (foreign)
7:40am
6-K
KZIA
Kazia Therapeutics Limited
17 Jun 22
Us Fda Awards Orphan Drug Designation (Odd) to Paxalisib
4:54pm